Eventide Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Eventide Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-408,542	Closed	-$16.2M	–	174
2024 Q1	$16.2M	Buy	+408,542	New	+$12.1M	0.25%	105

Eventide Asset Management's ALPN Position: Q2 2024 in Review

Eventide Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 408,542 shares — an estimated $16.2M sold.

Eventide Asset Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $16.2M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Eventide Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Eventide Asset Management sold 408,542 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $16.2M.
Eventide Asset Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Eventide Asset Management's Alpine Immune Sciences Inc position peaked at $16.2M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Eventide Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.